Three-year open protocol continuation study of oral tolerization with myelin antigens in multiple sclerosis and design of a phase III pivotal trial

Annals of the New York Academy of Sciences

Volumn 778, Issue , 1996, Pages 243-250

  Hohol, Marika J ^a   Khoury, Samia J ^a   Cook, Sandra L ^a   Orav, E John ^a   Hafler, David A ^a   Weiner, Howard L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; MYELIN BASIC PROTEIN; STEROID;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; INCIDENCE; INTRAVENOUS DRUG ADMINISTRATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MEDICAL ASSESSMENT; MULTIPLE SCLEROSIS; ORAL DRUG ADMINISTRATION; PHASE 3 CLINICAL TRIAL; PHENOTYPE; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

EID: 0029867975     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb21132.x     Document Type: Article

References (17)

1. WEINER, H. L. & D. A. HAFLER. 1988. Immunotherapy of multiple sclerosis. Ann. Neurol. 23: 211-222.
2. THE IFNB MULTIPLE SCLEROSIS STUDY GROUP AND THE UNIVERSITY OF BRITISH COLUMBIA MS/MRI ANALYSIS GROUP. 1995. Interferon beta-1 b in the treatment of multiple sclerosis: Final outcome of the randomized controlled trial. Neurology 45: 1277-1285.
3. JOHNSON, K. P., B. R. BROOKS, J. A. COHEN, C. C. FORD, J. GOLDSTEIN, R. P. LISAK, L. W. MYERS, H. S. PANITCH, J. W. ROSE, R. B. SCHIFFER, T. VOLLMER, L. P. WEINER, J. S. WOLINSKY & THE COPOLYMER 1 MULTIPLE SCLEROSIS STUDY GROUP. 1995. Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: Results of a phase III multicenter, double-blind, placebo-controlled trial. Neurology 45: 1268-1276.
4. WELLS, H. G. 1911. Studies on the chemistry of anaphylaxis (III). Experiments with isolated proteins, especially those of the hen's egg. J. Infect. Dis. 8: 147-171.
5. BRANDTZAEG, P. 1989. Overview of the mucosal immune system. Curr. Top. Microbiol. Immunol. 146: 13-28.
6. HIGGINS, P. & H. L. WEINER. 1988. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments. J. Immunol. 140: 440-445.
7. BITAR, D. & C. C. WHITACRE. 1988. Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein. Cell. Immunol. 112: 364-370.
8. BROD, S. A., A. AL-SABBGH, R. A. SOBEL, D. A. HAFLER & H. L. WEINER. 1991. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens. IV. Suppression of chronic relapsing disease in the Lewis rat and strain 13 guinea pig. Ann. Neurol. 29: 615-622.
9. AL-SABBAGH, A., A. MILLER, L. M. B. SANTOS & H. L. WEINER. 1994. Antigen-driven tissue-specific suppression following oral tolerance: Orally administered myelin basic protein suppresses proteolipid induced experimental autoimmune encephalomyelitis in the SJL mouse. Eur. J. Immunol. 24: 2104-2109.
10. NAGLER-ANDERSON, C., L. A. BOBER, M. E. ROBINSON, G. W. SISKIND & F. J. THORBEKE. 1986. Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen. Proc. Natl. Acad. Sci. USA 83: 7443-7446.
11. THOMPSON, H. S. G. & N. A. STAINES. 1986. Gastric administration of type II collagen delays the onset and severity of collagen-induced arthritis in rats. Clin. Exp. Immunol. 64: 581-586.
12. ZHANG, J. Z., C. S. Y. LEE, O. LIDER & H. L. WEINER. 1990. Suppression of adjuvant arthritis in Lewis rats by oral administration of type II collagen. J. Immunol. 145: 2489-2493.
13. NUSSENBLATT, R. B., R. R. CASPI, R. MAHDI, C. C. CHAN, F. ROBERGE, O. LIDER & H. L. WEINER. 1990. Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen. J. Immunol. 144(5): 1689-1695.
14. ZHANG, J. A., L. DAVIDSON, G. EISENBARTH & H. L. WEINER. 1991. Suppression of diabetes in NOD mice by oral administration of porcine insulin. Proc. Natl. Acad. Sci. USA 88: 10252-10256.
15. WEINER, H. L., G. A. MACKIN, M. MATSUI, E. J. ORAV, S. J. KHOURY, D. M. DAWSON & D. A. HAFLER. 1993. Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science 259: 1321-1324.
16. LIANG, K-Y. & S. L. ZEGER. 1986. Longitudinal data analyses using generalized linear models. Biometrika 73: 13-22.
17. FUKAURA, H., S. C. KENT, M. J. PIETRUSEWICZ, S. J. KHOURY, H. L. WEINER & D. A. HAFLER. 1996. Antigen-specific TGFβ1 secretion with bovine myelin oral tolerization in multiple sclerosis. 1996. This volume.